健帆生物(300529.SZ)：实际控制人董凡累计转让“健帆转债”126万张

Core Viewpoint - The company, Jianfan Bio, has announced that its controlling shareholder and actual controller, Mr. Dong Fan, will transfer 1,264,320 units of "Jianfan Convertible Bonds" by September 22, 2025, which represents 12.64% of the total issued convertible bonds [1] Group 1 - The transfer of convertible bonds is part of a planned divestment by the controlling shareholder [1] - The total amount of convertible bonds being transferred is significant, indicating a strategic move by the shareholder [1] - The transaction will take place through the Shenzhen Stock Exchange trading system [1]